阿替唑单抗
膀胱癌
佐剂
医学
肿瘤科
泌尿科
癌症
内科学
癌症研究
免疫疗法
彭布罗利珠单抗
作者
Thomas Powles,Ariel Galapo Kann,Daniel Castellano,Marine Gross‐Goupil,Hiroyuki Nishiyama,Sergio Bracarda,Jørgen Bjerggaard Jensen,Lydia Makaroff,Shusuan Jiang,Ja Hyeon Ku,Se Hoon Park,Òscar Reig,Dingwei Ye,Marco Maruzzo,Andrea Necchi,Rafael Morales‐Barrera,Emilio Francesco Giunta,Jae‐Lyun Lee,Giampaolo Tortora,Yüksel Ürün
标识
DOI:10.1056/nejmoa2511885
摘要
Among patients with muscle-invasive bladder cancer, ctDNA-guided adjuvant therapy with atezolizumab led to significantly longer disease-free survival and overall survival than placebo. (Funded by F. Hoffmann-La Roche; IMvigor011 ClinicalTrials.gov number, NCT04660344.).
科研通智能强力驱动
Strongly Powered by AbleSci AI